Newsroom
Newsroom
Blog Posts
We sat down with Dr. Kristy Hawkins, Co-Founder and Chief Scientific Officer at Antheia and Dr. Andrew Carpenter, Chief Scientific Officer at Phlow Corp. to...
Press Releases
Phlow Corp. and Antheia today announced an ongoing partnership to onshore production of essential medicines and establish more efficient, agile, and resilient pharmaceutical supply chains...
Industry News
Antheia founder Christina Smolke told CNBC’s Inside Wealth family offices’ patient capital makes them a good fit for investing in scientific breakthroughs....
Industry News
A Menlo Park biotech startup's substantial funding round signals growing interest in domestic production of critical medicine components....
Industry News
The U.S. relies heavily on pharmaceutical ingredients from other countries. Antheia wants to help reduce that dependence....
Industry News
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more....
Blog Posts
We sat down with Dr. Kristy Hawkins, Co-Founder and Chief Scientific Officer at Antheia and Dr. Andrew Carpenter, Chief Scientific Officer at Phlow Corp. to...
Press Releases
Phlow Corp. and Antheia today announced an ongoing partnership to onshore production of essential medicines and establish more efficient, agile, and resilient pharmaceutical supply chains...
Industry News
Antheia founder Christina Smolke told CNBC’s Inside Wealth family offices’ patient capital makes them a good fit for investing in scientific breakthroughs....
Industry News
A Menlo Park biotech startup's substantial funding round signals growing interest in domestic production of critical medicine components....
Industry News
The U.S. relies heavily on pharmaceutical ingredients from other countries. Antheia wants to help reduce that dependence....
Industry News
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more....
Industry News
Antheia founder Christina Smolke told CNBC’s Inside Wealth family offices’ patient capital makes them a good fit for investing in scientific breakthroughs....
Industry News
A Menlo Park biotech startup's substantial funding round signals growing interest in domestic production of critical medicine components....
Industry News
The U.S. relies heavily on pharmaceutical ingredients from other countries. Antheia wants to help reduce that dependence....
Industry News
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more....
Industry News
Antheia, a Menlo Park, California-based pharmaceutical ingredient maker, raised $56 million in Series C funding....
Industry News
Pharmaceutical ingredient manufacturer Antheia raised $56 million led by Global Health Investment Corp. at an undisclosed valuation. Cofounder and CEO Christina Smolke told Forbes she...
Press Releases
Phlow Corp. and Antheia today announced an ongoing partnership to onshore production of essential medicines and establish more efficient, agile, and resilient pharmaceutical supply chains...
Press Releases
New funding will support the company’s rapid growth trajectory and efforts to transform pharmaceutical supply chains with its advanced biomanufacturing platform....
Press Releases
Company awarded for its ability to outperform conventional manufacturing methods for critical pharmaceutical ingredients and rapidly reach commercial scale in the U.S....
Press Releases
Company successfully fulfills its first customer order; continues commercial scale production of thebaine and advances other critical pharmaceutical ingredients....
Press Releases
Company awarded government project agreement to onshore key pharmaceutical supply chains, alongside strategic investment from In-Q-Tel and Echo...
Blog Posts
We sat down with Dr. Kristy Hawkins, Co-Founder and Chief Scientific Officer at Antheia and Dr. Andrew Carpenter, Chief Scientific Officer at Phlow Corp. to...
Blog Posts
After a busy year marked by major commercial milestones for Antheia, we are excited to announce $56 million in Series C financing. With the support...